Abstract: Nineteen chiral tropos phosphorus ligands, based on a flexible (tropos) biphenol unit and a chiral P-bound alcohol (11 phosphites) or secondary amine (8 phosphoramidites), were screened, individually and as a combination of two, in various Rh-catalyzed asymmetric reactions. In the Rh-catalyzed asymmetric conjugate addition of phenylboronic acid to cyclic enones, enantiomeric excesses (ee's) up to 95 % were obtained with a 1:1 mixture of a phosphite [derived from (1R,2S)-2-(1-methyl-1-phenylethyl)cyclohexanol] and a phosphoramidite [derived from (S,S)-2,5-diphenylpyrrolidine]. In the mixed Rh precatalyst, which was characterized via 31 P-NMR, the biphenol-derived phosphite is free to rotate (tropos) while the biphenol-derived phosphoramidite shows a temperature-dependent tropos/atropos behavior (coalescence temperature = 310 K). The ligands were also screened in the hydrogenation of dehydro-α-amino acids and dehydro-β-amino acids. Ee's up to 98 % were obtained for the dehydro-α-amino acids, using the combination of a phosphite [derived from (1R,2S)-2-phenyl-1-cyclohexanol] and a phosphoramidite [derived from (S,S)-bis(α-methylbenzyl)amine]. The reaction was optimized by lowering the phosphite/phosphoramidite ratio to 0.25:1.75 with a resulting improvement of the product ee.
INTRODUCTION
The scene of asymmetric catalysis has been dominated for three decades by chiral bisphosphorus ligands (DIOP, DIPAMP, BINAP, DUPHOS, PENNPHOS, etc.) since the pioneering work of Knowles, Kagan, and Noyori [1] . Only recently (2000) (2001) (2002) (2003) (2004) (2005) , monodentate P-ligands have been applied successfully in combination with different metal sources (Rh, Cu, Ru, Ir, Pd) in a number of reactions (including hydrogenation, allylic substitution, conjugate addition, allylation, etc.) providing high enantioselectivities, sometimes even higher than the bidentate ligands [2] . In particular, readily accessible and highly diverse chiral monodentate ligands such as phosphoramidites, phosphites, and phosphonites have been introduced, which comprise different units attached to the phosphorus atom: a chi-
RHODIUM-CATALYZED ASYMMETRIC CONJUGATE ADDITION OF PHENYLBORONIC ACID TO CYCLIC ENONES
The asymmetric Rh-catalyzed conjugate addition of aryl-and vinylboronic acids, originally reported by Miyaura and Hayashi, has become the method of choice for the stereoselective introduction of an aryl or a vinyl group in the β position of a variety of electron-deficient olefins [8] . Excellent enantioselectivities were obtained using both bidentate (binap, segphos, chiraphos, diphosphonites, diphosphites, amidomonophosphines, chiral dienes, chiral phosphine-olefins) and, more recently, monodentate ligands (binaphtholic phosphoramidites) [9] .
The ligand collection ( Fig. 1 ) was screened in the conjugate addition of phenylboronic acid to 2-cyclohexenone 21, using 1.5 mol % [Rh(C 2 H 4 ) 2 Cl] 2 and a total of 6 mol % of ligands (Rh:L = 1:2) [7c]. The reaction was performed using KOH (1 equiv) as base [10] , in a 10:1 dioxane/water solution at room temperature overnight. A few selected results are presented in Table 1 . In general, when the chiral ligands were used individually (homocombinations) the phosphites gave catalysts more efficient and enantioselective than the phosphoramidites. However, the enantiomeric excesses (ee's) were only moderate, and the best ee was 70 % with phosphite 6-P(O) 2 O ( 8) , showing that it is the phosphoramidite which determines the absolute configuration of the reaction product. Again, the synergistic effect of the heterocombination is remarkable. The effect of the ring-size was then evaluated. 2-Cyclopentenone 20 and 2-cycloheptenone 22 were investigated using all the homocombinations and several heterocombinations (see Table 1 for selected results). The best results were again obtained using the heterocombinations containing the 2,5-diphenylpyrrolidine phosphoramidites [18-P(O) complex. The metal complexes containing biphenolic tropos ligands (phosphites or phosporamidites) were defined "induced atropisomeric" by Alexakis [3a] and "fluxionally atropisomeric" by Reetz [4c] . However, no proof was ever presented regarding their tropos or atropos nature. A variable-temperature 31 P-NMR study of the ligands 6-P(O) 2 O and 19-P(O) 2 N and of the Rh complexes which originate from their homo-(2L a , 2L b ) and heterocombination (L a + L b ) was undertaken, using Rh(acac)(C 2 H 4 ) 2 as the metal source. 31 P-NMR studies demonstrate the tropos nature of phosphite 6-P(O) 2 O in the Rh complex even at low temperature (230 K), while the spectra of the Rh complex of phosphoramidite 19-P(O) 2 N showed a typical coalescence behavior (coalescence temperature T C = 320 K in toluene-d 8 ;
The spectra of the Rh complexes resulting from the combination of phosphite 6-P(O) 2 O and phosphoramidite 19-P(O) 2 N account for the presence of the L a RhL a and L b RhL b homocomplexes (ca. 40 %) and of the L a RhL b heterocomplex (ca. 60 %) [6] . At 375 K, the heterocomplex L a RhL b has a tropos phosphite and a tropos phosphoramidite. The coalescence temperature (T C ) is 310 K, and by cooling to 230 K, it is possible to identify one of the two possible diastereomers differing for the configuration at the phosphoramidite atropisomeric biphenol (which can be aR or aS), while the phosphite biphenol remains free to rotate (tropos). The free energy barrier to the biphenol rotation in the L a RhL b heterocomplex was calculated in toluene-d 8 ∆G ≠ = 14.5 ± 0.2 kcal mol -1 [7c] .
In summary, of the 10 possible different precatalysts, we detected the presence of five species: four homocomplexes (total ca. 40 %) Rh [6- 
, and one heterocomplex (ca. 60 %) Rh [6- 
Performing the reaction at 298 K (15 h, 100 % yield, 95 % ee), near the heterocomplex coalescence temperature (310 K), seems particularly important. In fact, the ee slightly decreased at both 353 K (15 h, 100 % yield, 86 % ee) and 283 K (60 h, 100 % yield, 93 % ee). We also prepared the (R)-and the (S)-binaphthol analogs of phosphoramidite 19-P(O) 2 N and tested each of them in combination with phosphite 6-P(O) 2 O. Surprisingly, the combination of 6-P(O) 2 O with either the (S)-binaphthol analog [50 % yield, 46 % ee, (R)] or the (R)-binaphthol analog [70 % yield, 72 % ee, (R)] were both considerably less effective than the original biphenol-based combination [100 % yield, 95 % ee, (R)]. These experiments further emphasize the role of the tropos/atropos biphenol near the coalescence temperature in promoting high enantioselectivities: a case where a conformationally mobile catalyst is capable of self-adaptation and substrate-matching better than a rigid system.
RHODIUM-CATALYZED ASYMMETRIC HYDROGENATION
The hydrogenation reactions were initially performed on methyl 2-acetamidoacrylate (in dichloromethane, overnight, at 1 bar hydrogen pressure, using 1 mol % of Rh(COD) 2 BF 4 and a total of 2 mol % of ligands). The ligands were first screened individually (homocombinations): in general, the phosphites were much more reactive than the phosphoramidites, allowing for excellent yields and moderate ee's. By mixing two different phosphoramidite ligands, the hydrogenation product was generally obtained in moderate ee (lower than with the corresponding homocombinations), and poor conversion. The phosphite-phosphite combinations gave the product quantitatively, but with poor ee's. The phosphite-phosphoramidite combinations were the most productive, retaining the phosphite high reactivity (resulting in high conversions) and often improving the enantioselectivities compared to the homocombinations (for selected results, see Table 2 ). The best combination 4-P(O) 2 O/13-P(O) 2 N (Table 2, entry 7) gave (S)-N-acetylalanine methyl ester in 87 % ee (100 % yield), while the corresponding mismatched combination [4-P(O) 2 O/12-P(O) 2 N, Table 2, entry 6] gave (R)-N-acetylalanine methyl ester in 35 % ee (100 % yield). The effect of the solvent was then studied, and it was noticed that the use of more polar solvents (THF, EtOAc, alcohols) was beneficial to the enantioselectivity of the reaction; in particular, when isopropanol was used, the product was obtained in 94 % ee and 100 % yield (Table 2, entry 9) . Selected heterocombinations were also tested in the hydrogenation of 2-acetamidoacrylic acid: under the optimized conditions (iPrOH, room temperature, 1 bar hydrogen pressure, overnight) the combination of ligands 4-P(O) 2 O and 13-P(O) 2 N gave (S)-N-acetylalanine in 94 % ee and 100 % yield [7] . Further experiments were carried out in collaboration with Prof. J. G. de Vries, Dr. A. H. M. de Vries, and Dr. L. Lefort (DSM Pharma Chemicals-Advanced Synthesis, Catalysis, and Development) [7b] . For the hydrogenation of methyl 2-acetamidocinnamate, the ligand screening was performed with a Premex-96 multireactor (room temperature in dichloromethane, with 10 bar hydrogen pressure). The homocombinations gave results ranging from 6 % ee and 2 % conversion [ Table 3 , entry 2, 13-P(O) 2 N] to 64 % ee and 100 % conversion [ Table 3 , entry 1, 4-P(O) 2 O]. The best result was obtained with the heterocombination of ligands 4-P(O) 2 O and 13-P(O) 2 N, allowing for 85 % ee and 82 % conversion (Table 3 , entry 3).
The solvent screening was carried out using a multireactor autoclave (Argonaut Endeavor TM ): in particular, isopropanol allowed for 95 % ee and 100 % conversion at 5 bar hydrogen pressure (Table 3 , entry 4) [7b] .
Also for the hydrogenation of 2-acetamidocinnamic acid, excellent results were obtained with the combination 4-P(O) 2 O/13-P(O) 2 N (93 % ee, 100 % conversion). Substituted 2-acetamidocinnamic acids were then tested using the heterocombination 4-P(O) 2 O and 13-P(O) 2 N. The introduction of a Cl substituent in the phenyl ring resulted in a significant increase of the enantioselectivity: excellent enantioselectivities and quantitative conversions were obtained in iPrOH with both N-acetyl-2-chlorodehydrophenylalanine [100 % yield, 98 % ee (S) at 10 bar and 100 % yield, 95 % ee (S) at 25 bar] and N-acetyl-4-chlorodehydrophenylalanine [100 % yield, 97 % ee (S) at 10 bar] as substrates [7b] .
The enantioselective hydrogenation of β-acylamino acrylates gives access to chiral β-amino acid derivatives which are important pharmaceutical building blocks. C. GENNARI et al. 
Rate comparisons and improvement of the heterocombination ligand ratio
A comparison of the rates of the hydrogenation of methyl 2-acetamidocinnamate using single ligands 4-P(O) 2 O and 13-P(O) 2 N and their heterocombination proved that phosphite 4-P(O) 2 O was the most active (with full conversion within 30 min and 79 % ee), while phosphoramidite 13-P(O) 2 N was much slower (3 % conversion in 5 h, 36 % ee). When the 1:1 heterocombination of ligands 4-P(O) 2 O and 13-P(O) 2 N was employed, the highest enantioselectivity (95 % ee) was obtained with complete conversion in 2 h (definitely slower than the phosphite-catalyzed, but much faster than the phosphoramidite-catalyzed reaction). We envisaged that, by modifying the L a :L b ratio, we could influence the concentration of the different species and possibly the stereochemical outcome of the reaction. In particular, we speculated that lowering the ratio 4-P(O) 2 O:13-P(O) 2 N, but keeping constant the (L a + L b ):Rh ratio (equal to 2), less Rh complex containing only 4-P(O) 2 O (very active, but less enantioselective) would be present in solution. This would in turn favor the concentration of mixed complexes containing both 4-P(O) 2 O and 13-P(O) 2 N, apparently the most selective ones. The species containing only 13-P(O) 2 N would become predominant but, being almost inactive, should not influence significantly the reaction outcome. A screening of the relative ratio of the two ligands was carried out in isopropanol. The best L a :L b ratio identified was 0.25:1.75 for 4-P(O) 2 O and 13-P(O) 2 N, respectively, which gave the hydrogenation product in 98 % ee and 79 % conversion (iPrOH as solvent: 79 % ee and 100 % conversion with 4-P(O) 2 O; 36 % ee and 2 % conversion with and 13-P(O) 2 N; 95 % ee and 100 % conversion with a 1:1 ratio of 4-P(O) 2 O and 13-P(O) 2 N) [7b].
The same study was then performed for the hydrogenation of methyl 2-acetamidoacrylate, and similar trends to those identified in the hydrogenation of methyl 2-acetamidocinnamate were observed. The best L a :L b ratio identified was again 0.25:1.75 for 4-P(O) 2 O and 13-P(O) 2 N, respectively, allowing for 98 % ee and 100 % conversion (iPrOH as solvent: 61 % ee and 100 % conversion with 4-P(O) 2 O; 89 % ee and 3 % conversion with 13-P(O) 2 N; 94 % ee and 100 % conversion with a 1:1 ratio of 4-P(O) 2 O and 13-P(O) 2 N) [7b] .
When the rates of the hydrogenation of methyl (Z)-3-acetamidocrotonate using ligands 3-P(O) 2 O, 19-P(O) 2 N, and their heterocombination were measured by hydrogen uptake, a different behavior was displayed: in this case, both phosphite 3-P(O) 2 O and phosphoramidite 19-P(O) 2 N give rise to very active catalysts, that allow for full conversion within 1 h, while the reaction performed using the heterocombination is slower, although more enantioselective. This result was confirmed by the study of the relative ratio of the two ligands (iPrOH at 25 bar hydrogen pressure), which showed that the 1:1 ratio 3-P(O) 2 O/19-P(O) 2 N was the most effective, both in terms of enantioselectivity and conversion (71 % ee, 100 % conversion). An excess of either one of the two ligands reduces the overall enantioselectivity [iPrOH as solvent: 19 % ee and 100 % conversion with 3-P(O) 2 O; 22 % ee and 91 % conversion with and 19-P(O) 2 N; 60 % ee and 83 % conversion with a 0.5:1.5 ratio 3-P(O) 2 O/19-P (O) 2 N] [7b] .
A simple mathematical model for a better understanding of the variation of the ee with the phosphite/phosphoramidite ratio was developed [7b] . The model can be used to fit the experimental data and consequently provides semiquantitative information on values that are not accessible via the experience, such as the rate of the heterocomplexes relative to the rate of the homocomplexes. It also allows an estimation of the distribution of the homo/heterocomplexes. The model also gives guidelines whether it is pertinent to screen outside the ratio of 1:1 for the ligands and how much improvement could be expected by doing so. In summary, the new concept of using a nonequivalent amount of the two ligands (while keeping total L:Rh = 2) is a novel powerful tool to enhance enantioselectivity in selected cases.
